Latest Comments on ChinaBio Today's Articles

1. User 282993 on Sinovac Set to Move Listing to NASDAQ: This stock has proven it's a winner in more ways than one. As soon... more »
2. User 507387 on Week in Review: Major Investments in China Biotech Companies: What does the following messge mean? There are too many technical... more »
3. Talavera on Sinovac Set to Move Listing to NASDAQ: The Talavera indicators chart show sva as a winner for this... more »
4. User 507387 on Sinovac Set to Move Listing to NASDAQ: That SVA moves to NASDAQ means more price fluctuation in the... more »
5. Tom B on Pfizer's Cutbacks Reflect Difficulties Facing Big Pharma: "The key strategy is cost management not revenue growth." In... more »
6. medsearch on Pfizer's Cutbacks Reflect Difficulties Facing Big Pharma: With Pfizer, J & J, and Merck cutting jobs in droves, olther... more »
7. desicon on Pfizer's Cutbacks Reflect Difficulties Facing Big Pharma: PFE is following the tried and proven business methods. The key... more »
8. Glen Bradford on Biostar Raises $3.6 Million: BSPM Disclosure:... more »
9. User 368368 on Sinovac Set to Move Listing to NASDAQ: The specialist was keeping SVA down to be able to buy back all the... more »
10. User 283977 on Sinovac Set to Move Listing to NASDAQ: Hi Fran... this is what Mr. Weidong Yin, Chairman, President... more »
11. fran grady on Sinovac Set to Move Listing to NASDAQ: Does this move increase the number of potential investors? more »
12. stan wunderlich on NeoStem Closes China Biopharma Acquisition to Boost Revenues: Dr. Robin Smith deserves all the credit for her tirelless effort... more »
13. Indiancro on China Biotech Week in Review: Is CRO Consolidation a New Theme?: I would like to know your viewpoint on Indian CRO's. I would... more »
14. Alphameister on Tianyin Pharma Forms JV to Expand Antibiotics Business : TPI has been one of my favorite stocks, seemingly offering great... more »
15. huangthomas on Simcere Gains Majority Control of Vaccine Subsidiary: The most urgent thing for Chinese vaccine makers to do is to... more »